news

LEUKOCARE and Sanofi Pasteur sign cooperation agreement for vaccine stabilization

Posted: 25 July 2011 | | No comments yet

LEUKOCARE AG, announced the signing of a cooperation agreement with Sanofi Pasteur…

LEUKOCARE LOGO

LEUKOCARE AG, a privately-owned specialist company for protein stabilization and biological surface coating today announced the signing of a cooperation agreement with Sanofi Pasteur, the vaccines division of Sanofi. (EURONEXT: SAN and NYSE: SNY). As part of this cooperation, Sanofi Pasteur will explore LEUKOCARE’s SPS platform technology to enhance the shelf-life of selected vaccine formulations.

LEUKOCARE’s Stabilizing and Protecting Solutions (SPS) are employed in the biopharmaceutical, medical device and diagnostics industries to enhance the shelf-life of proteins and to enable terminal sterilization by irradiation or Ethylene Oxide. Terminal sterilization allows for a significant reduction in production costs by avoiding complex aseptic production and at the same time, improves product safety, as most sources of error can be excluded in one single step.

Related organisations

,